Related references
Note: Only part of the references are listed.Molecular Characterization of Multidrug-Resistant Pseudomonas aeruginosa Isolates in Hospitals in Myanmar
Tatsuya Tada et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Prevalence of the crpP gene conferring decreased ciprofloxacin susceptibility in enterobacterial clinical isolates from Mexican hospitals
Victor M. Chavez-Jacobo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Diversity of carbapenemases in clinical isolates: The emergence of blaVIM-5 in Bangladesh
Nadira Naznin Rakhi et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2019)
Challenge of drug resistance in Pseudomonas aeruginosa: clonal spread of NDM-1-positive ST-308 within a tertiary hospital
Ka Lip Chew et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
Ceftolozane/Tazobactam Susceptibility Testing in Extended-Spectrum Betalactamase- and Carbapenemase-Producing Gram-Negative Bacteria of Various Clonal Lineages
Carlo Pazzini et al.
EUROPEAN JOURNAL OF MICROBIOLOGY AND IMMUNOLOGY (2019)
CrpP Is a Novel Ciprofloxacin-Modifying Enzyme Encoded by the Pseudomonas aeruginosa pUM505 Plasmid
Victor M. Chavez-Jacobo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Intraclonal variations of resistance and phenotype in Pseudomonas aeruginosa epidemic high-risk clone ST308: A key to success within a hospital?
F. Abdouchakour et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2018)
VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey
Guelsah Malkocoglu et al.
MICROBIAL DRUG RESISTANCE (2017)
Molecular Characterization of Carbapenemase-Producing Pseudomonas aeruginosa of Czech Origin and Evidence for Clonal Spread of Extensively Resistant Sequence Type 357 Expressing IMP-7 Metallo-β-Lactamase
Costas C. Papagiannitsis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Ceftolozane-Tazobactam Activity against Pseudomonas aeruginosa Clinical Isolates from US Hospitals: Report from the PACTS Antimicrobial Surveillance Program, 2012 to 2015
Dee Shortridge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Draft Genome Sequence of an IMP-7-Producing Pseudomonas aeruginosa Bloodstream Infection Isolate from Australia
K. L. McCarthy et al.
GENOME ANNOUNCEMENTS (2017)
Detection of carbapenemase activity in Enterobacteriaceae: comparison of the carbapenem inactivation method versus the Carba NP test
Nathalie Tijet et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Diversity of Molecular Mechanisms Conferring Carbapenem Resistance to Pseudomonas aeruginosa Isolates from Saudi Arabia
Mohamed H. Al-Agamy et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2016)
A Novel Integron Gene Cassette Harboring VIM-38 Metallo-β-lactamase in a Clinical Pseudomonas aeruginosa Isolate
Fatih Saban Beris et al.
ANNALS OF LABORATORY MEDICINE (2016)
Dissemination of Carbapenemase-Producing Enterobacteriaceae and Pseudomonas aeruginosa in Romania
Laurent Dortet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Molecular analysis of the integrons of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates collected by nationwide surveillance programs across Japan
Yoko Mano et al.
BMC MICROBIOLOGY (2015)
The increasing threat of Pseudomonas aeruginosa high-risk clones
Antonio Oliver et al.
DRUG RESISTANCE UPDATES (2015)
Characterisation of an IMP-7-producing ST357 Pseudomonas aeruginosa isolate detected in Denmark using whole genome sequencing
Anette M. Hammerum et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology
Anais Potron et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Identification of a Pseudomonas aeruginosa co-producing NDM-1, VIM-5 and VIM-6 metallo β-lactamases in Denmark using whole-genome sequencing
Mikala Wang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa: a molecular epidemiological study
Matthias Willmann et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Identifies Pseudomonas aeruginosa High-Risk Clones
Nadege Cabrolier et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Molecular Epidemiology of Beta-Lactamases in Ceftazidime-Resistant Pseudomonas aeruginosa Isolates
Halil Er et al.
MIKROBIYOLOJI BULTENI (2015)
The Presence of OXA Type Carbapenemases in Pseudomonas Strains: First Report from Turkey
Fatma Esenkaya Tasbent et al.
MIKROBIYOLOJI BULTENI (2015)
Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
Jonathan C. Cho et al.
PHARMACOTHERAPY (2015)
The Carbapenem Inactivation Method (CIM), a Simple and Low-Cost Alternative for the Carba NP Test to Assess Phenotypic Carbapenemase Activity in Gram-Negative Rods
Kim van der Zwaluw et al.
PLOS ONE (2015)
In Silico Detection and Typing of Plasmids using PlasmidFinder and Plasmid Multilocus Sequence Typing
Alessandra Carattoli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Characterization of novel VIM carbapenemase, VIM-38, and first detection of GES-5 carbapenem-hydrolyzing β-lactamases in Pseudomonas aeruginosa in Turkey
Meryem Iraz et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2014)
Faecal carriage of Pseudomonas aeruginosa in healthy humans: antimicrobial susceptibility and global genetic lineages
Vanesa Estepa et al.
FEMS MICROBIOLOGY ECOLOGY (2014)
Prevalence and molecular characterisation of metallo-beta-lactamase producing strains of imipenem-resistant Pseudomonas aeruginosa in Turkey
N. Ozkalay Yilmaz et al.
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY (2014)
Antimicrobial activity of ceftolozane/tazobactam tested against Pseudomonas aeruginosa and Enterobacteriaceae with various resistance patterns isolated in European hospitals (2011-12)
Helio S. Sader et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Epidemiology and carbapenem resistance mechanisms of carbapenem-non-susceptible Pseudomonas aeruginosa collected during 2009-11 in 14 European and Mediterranean countries
Mariana Castanheira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates
Yun Qing et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2014)
Biological Markers of Pseudomonas aeruginosa Epidemic High-Risk Clones
Xavier Mulet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Antimicrobial Activity of Ceftolozane-Tazobactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa with Various Resistance Patterns Isolated in U.S. Hospitals (2011-2012)
David J. Farrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Genetic diversity of clinical Pseudomonas aeruginosa isolates in a public hospital in Spain
Margarita Gomila et al.
BMC MICROBIOLOGY (2013)
Genetic Markers of Widespread Extensively Drug-Resistant Pseudomonas aeruginosa High-Risk Clones
Gabriel Cabot et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Spread of the blaIMP-13 gene in French Pseudomonas aeruginosa through sequence types ST621, ST308 and ST111
Damien Fournier et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Identification of acquired antimicrobial resistance genes
Ea Zankari et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Multilocus Sequence Typing of Total-Genome-Sequenced Bacteria
Mette V. Larsen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Pseudomonas aeruginosa Exhibits Frequent Recombination, but Only a Limited Association between Genotype and Ecological Setting
Timothy J. Kidd et al.
PLOS ONE (2012)
Rapid Detection of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann et al.
EMERGING INFECTIOUS DISEASES (2012)
Antimicrobial Activity of CXA-101, a Novel Cephalosporin Tested in Combination with Tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis Strains Having Various Resistance Phenotypes
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Regional Spread of Pseudomonas aeruginosa ST357 Producing IMP-7 Metallo-beta-Lactamase in Central Europe
Jaroslav Hrabak et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Wide Dispersion of ST175 Clone despite High Genetic Diversity of Carbapenem-Nonsusceptible Pseudomonas aeruginosa Clinical Strains in 16 Spanish Hospitals
Maria Garcia-Castillo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Global Spread of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann et al.
EMERGING INFECTIOUS DISEASES (2011)
Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance
Neil Woodford et al.
FEMS MICROBIOLOGY REVIEWS (2011)
Carbapenem Resistance among Pseudomonas aeruginosa Strains from India: Evidence for Nationwide Endemicity of Multiple Metallo-β-Lactamase Clones (VIM-2,-5,-6, and-11 and the Newly Characterized VIM-18)
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-β-lactamase in Slovakia
Daniela Ohlasova et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying the IMP-1 Metallo-β-Lactamase gene in a University hospital in Turkey
Osman Birol Ozgumus et al.
MICROBIAL DRUG RESISTANCE (2007)
Population structure of Pseudomonas aeruginosa
Lutz Wiehlmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
David M. Livermore et al.
TRENDS IN MICROBIOLOGY (2006)
PER-1 is still widespread in Turkish hospitals among Pseudomonas aeruginosa and Acinetobacter spp.
F Kolayli et al.
FEMS MICROBIOLOGY LETTERS (2005)
Metallo-β-lactamases:: the quiet before the storm?
TR Walsh et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Detection of VIM-5 metallo-β-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey
G Bahar et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital
L Poirel et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America:: report from the SENTRY antimicrobial surveillance programme
MA Toleman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2002)
Carbapenem-resistant Pseudomonas aeruginosa in Malaysia producing IMP-7 β-lactamase
SE Ho et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
blaVIM-2 Cassette-containing novel integrons in metallo-β-lactamase-producing Pseudomonas aeruginosa and Pseudomonas putida isolates disseminated in a Korean hospital
K Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new bla(IMP) allele, bla(IMP-7)
AP Gibb et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Share Paper
